title: [Update on anaphylactic shock treatment recommendations: what's new in the use of epinephrine?].
abstract: In 1998, the Sociedad Argentina de Pediatría issued the recommendation of the treatment of anaphylactic shock. While this recommendation suggested the use of subcutaneous epinephrine, currently the intramuscular via is considered the most appropriate one. Pharmacological aspects determine this preference. For outpatient treatment, the correct use of autoinjectors can control anaphylaxis quickly and effectively. The use of other medications in the proposed 1998 recommendation remains unchanged.
authors.forename: César Martín
authors.initials: CM
authors.lastname: Bózzola
authors.forename: Ricardo J
authors.initials: RJ
authors.lastname: Saranz
authors.forename: Alejandro
authors.initials: A
authors.lastname: Lozano
authors.forename: María Elena
authors.initials: ME
authors.lastname: Cáceres
authors.forename: Paula
authors.initials: P
authors.lastname: Sarraquigne
authors.forename: Andrea Irene
authors.initials: AI
authors.lastname: Mariño
authors.forename: Raúl Vicente
authors.initials: RV
authors.lastname: Boudet
authors.forename: Gloria
authors.initials: G
authors.lastname: Bandín
authors.forename: Víctor
authors.initials: V
authors.lastname: Skrie
mesh_terms: D000707:Anaphylaxis / Q000188:drug therapy*; D002648:Child; D004837:Epinephrine / Q000008:administration & dosage*; D006801:Humans
chemical_list: D004837:Epinephrine